Iterative Health

Iterative Health has raised a total of $180 million across two funding rounds, including a $150 million Series B in January 2022. Founded by Jonathan Ng, the Cambridge, Massachusetts-based company employs 51–200 people and specializes in AI-driven precision medicine for gastroenterology. Its tools, such as SKOUT, analyze endoscopic images and clinical data to optimize clinical trials for inflammatory bowel disease and colorectal cancer. Key investors include Insight Partners and Clearlake Capital Group. With an estimated valuation of $500 million, Iterative Health is positioned for continued innovation and growth in AI-powered healthcare solutions.